BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Jun 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-05-31

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-31	Common Stock	M	16896	$39.06	Acquired	71235	Direct
2016-05-31	Common Stock	S	16896	$90.00	Disposed	54339	Direct
2016-05-31	Common Stock	S	3945	$89.35	Disposed	50394	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-31	Stock Option (Right to buy) Common Stock	$39.06	M	16896	Acquired	2022-05-28	Common Stock (16896)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on May 9, 2016.

F2: All shares were sold at the same price.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.